RESEARCHER PROFILE

Jan Richter

← Back to The Cyprus Institute of Neurology & Genetics - Postgraduate Education

J

The Cyprus Institute of Neurology & Genetics - Postgraduate Education

Virus-based gene therapy researchViral Infections and Immunology ResearchHereditary Neurological DisordersNeurogenetic and Muscular Disorders ResearchSARS-CoV-2 and COVID-19 Research

Jan Richter works in Virus-based gene therapy research, Viral Infections and Immunology Research, Hereditary Neurological Disorders, Neurogenetic and Muscular Disorders Research, SARS-CoV-2 and COVID-19 Research. Recorded institutional associations include The Cyprus Institute of Neurology & Genetics - Postgraduate Education, Cyprus Institute of Neurology and Genetics.

53Publications
1,308Citations
20H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Recommendations for enterovirus diagnostics and characterisation within and beyond Europe

    2018 · 258 citations
  2. Epidemiology of respiratory syncytial virus in children in Cyprus during three consecutive winter seasons (2010–2013): age distribution, seasonality and association between prevalent genotypes and disease severity

    2014 · 88 citations
  3. Intrathecal gene therapy rescues a model of demyelinating peripheral neuropathy

    2016 · 79 citations
  4. AAV9-mediated Schwann cell-targeted gene therapy rescues a model of demyelinating neuropathy

    2021 · 64 citations
  5. Gene replacement therapy in a model of Charcot-Marie-Tooth 4C neuropathy

    2019 · 63 citations
  6. Molecular typing of enteroviruses associated with viral meningitis in Cyprus, 2000–2002

    2006 · 61 citations
  7. Aetiology of Acute Respiratory Tract Infections in Hospitalised Children in Cyprus

    2016 · 59 citations
  8. A translatable RNAi-driven gene therapy silences PMP22/Pmp22 genes and improves neuropathy in CMT1A mice

    2022 · 54 citations
  9. Gene therapy targeting oligodendrocytes provides therapeutic benefit in a leukodystrophy model

    2016 · 48 citations
  10. Intrathecal gene therapy in mouse models expressing CMT1X mutations

    2018 · 48 citations
  11. Intraneural GJB 1 gene delivery improves nerve pathology in a model of X ‐linked C harcot– M arie– T ooth disease

    2015 · 47 citations
  12. Gene replacement therapy after neuropathy onset provides therapeutic benefit in a model of CMT1X

    2019 · 42 citations
  13. Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19

    2021 · 41 citations
  14. Phylogenetic Patterns of Human Coxsackievirus B5 Arise from Population Dynamics between Two Genogroups and Reveal Evolutionary Factors of Molecular Adaptation and Transmission

    2013 · 36 citations
  15. Efficacy of AAV serotypes to target Schwann cells after intrathecal and intravenous delivery

    2021 · 34 citations
  16. Molecular typing and epidemiology of enteroviruses in Cyprus, 2003–2007

    2011 · 23 citations
  17. A European multicentre evaluation of detection and typing methods for human enteroviruses and parechoviruses using RNA transcripts

    2019 · 21 citations
  18. The first human case of neuroinvasive West Nile virus infection identified in Cyprus

    2017 · 20 citations
  19. Complete Genome Sequence of West Nile Virus (WNV) from the First Human Case of Neuroinvasive WNV Infection in Cyprus

    2017 · 20 citations
  20. Molecular epidemiology of enteroviruses in Cyprus 2008-2017

    2019 · 20 citations
  21. AAV9-mediated SH3TC2 gene replacement therapy targeted to Schwann cells for the treatment of CMT4C

    2023 · 20 citations
  22. Newly emerging C group enteroviruses may elude diagnosis due to a divergent 5′-UTR

    2013 · 19 citations
  23. Circulation of enteroviruses in Cyprus assessed by molecular analysis of clinical specimens and sewage isolates

    2011 · 18 citations
  24. Molecular epidemiology of rhinoviruses in Cyprus over three consecutive seasons

    2014 · 15 citations
  25. The Prevalence of Antibodies against Sandfly Fever Viruses and West Nile Virus in Cyprus

    2019 · 14 citations
  26. Genomic Epidemiology of the SARS-CoV-2 Epidemic in Cyprus from November 2020 to October 2021: The Passage of Waves of Alpha and Delta Variants of Concern

    2022 · 13 citations
  27. Gene delivery targeted to oligodendrocytes using a lentiviral vector

    2014 · 12 citations
  28. Molecular epidemiology of SARS-CoV-2 in Cyprus

    2021 · 11 citations
  29. Mycoplasma pneumoniae as a cause of vulvar ulcers in a non-sexually active girl: a case report

    2017 · 9 citations
  30. Analysis of enterovirus and adenovirus presence in swimming pools in Cyprus from 2007–2008

    2011 · 8 citations
  31. 2005 Poliovirus eradication: poliovirus presence in Cyprus 2 years after

    2008 · 6 citations
  32. Association of Epstein-Barr virus latently expressed genes with multiple sclerosis

    2021 · 6 citations
  33. A dose escalation and safety study of AAVrh10-mediated Schwann cell-targeted gene therapy for CMT1X

    2025 · 6 citations
  34. Molecular epidemiology of influenza A virus infection in Cyprus in four consecutive seasons (2009 pandemic–2013)

    2013 · 5 citations
  35. In depth analysis of Cyprus-specific mutations of SARS-CoV-2 strains using computational approaches

    2021 · 4 citations
  36. Introduction, Spread and Impact of the SARS-CoV-2 Omicron Variants BA.1 and BA.2 in Cyprus

    2022 · 4 citations
  37. Exposure to Airborne SARS-CoV-2 in Four Hospital Wards and Icus of Cyprus. A Detailed Study Accounting for Day-to-Day Operations and Aerosol Generating Procedures

    2022 · 3 citations
  38. Aetiology of Community-Acquired Pneumonia and the Role of Genetic Host Factors in Hospitalized Patients in Cyprus

    2023 · 3 citations
  39. Characterization of IgG Antibody Response against SARS-CoV-2 (COVID-19) in the Cypriot Population

    2021 · 2 citations
  40. Gene Therapy in a Model of CMT1X Neuropathy Using a Lentiviral Vector (S6.005)

    2014 · 1 citations
  41. The life cycle of Puccinia digitariae on Digitaria eriantha and Solanum species in South Africa

    2022 · 1 citations
  42. Prevalence of Viral and Bacterial Co-Infections in SARS-CoV-2-Positive Individuals in Cyprus 2020–2022

    2025 · 1 citations
  43. Epstein–Barr Virus and Multiple Sclerosis: Mechanistic Insights into Virus-Driven Autoimmunity

    2026 · 1 citations
  44. Recommendations for enterovirus diagnostics and characterisation within and beyond Europe

    2018 · 0 citations
  45. Gene Therapy in a Model of CMT1X Neuropathy Using a Lentiviral Vector (I6-1.003)

    2014 · 0 citations
  46. Gene therapy after onset of neuropathy provides therapeutic benefit in a model of CMT1X (S58.004)

    2019 · 0 citations
  47. The life cycle of Puccinia digitariae on Digitaria eriantha and Solanum species in South Africa

    2022 · 0 citations
  48. Additional file 1 of In depth analysis of Cyprus-specific mutations of SARS-CoV-2 strains using computational approaches

    2021 · 0 citations
  49. Aetiology of community-acquired pneumonia and the role of genetic host factors in hospitalized patients

    2024 · 0 citations
  50. The Role of TLR3 rs3775291 Variant in West Nile Virus Infection: A Case-Control Study

    2025 · 0 citations

← Return to the university profile